Troy Cox, Director at MapLight Therapeutics, Inc. (MPLT), bought 15,620 shares at $9.52 ($149K) on 2026-07-28, disclosed to the SEC on 2026-07-28.
Director Troy Cox purchased 15,620 shares of MapLight Therapeutics for $148,702 at $9.52, marking the largest insider purchase in the company's history. This move comes as the stock has crashed nearly 70% from its 52-week high following mixed Phase II trial results for its schizophrenia drug.
MPLT is trading at $12.29, down 67.24% over the last 5 days and 62.97% over the last 30 days, placing it 69.14% below its 52-week high of $39.82.
Something here stands out, but not much.
| Filing → |
| FMI | SELL | 2018-05-17 | $333K | — | Filing → |
| FMI | SELL | 2018-05-09 | $989K | — | Filing → |
| FMI | SELL | 2018-02-20 | $1.2M | — | Filing → |